Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation

AIMS: Warfarin, a vitamin K antagonist (VKA), has been the standard of care for stroke prevention in patients with atrial fibrillation (AF). Aspirin is recommended for low-risk patients and those unsuitable for warfarin. Apixaban is an oral anticoagulant that has demonstrated better efficacy than wa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dorian, Paul, Kongnakorn, Thitima, Phatak, Hemant, Rublee, Dale A., Kuznik, Andreas, Lanitis, Tereza, Liu, Larry Z., Iloeje, Uchenna, Hernandez, Luis, Lip, Gregory Y.H.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Basic Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4104492/
https://ncbi.nlm.nih.gov/pubmed/24513791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars